Key clinical point: A validated disease risk index was developed for pediatric patients with acute myeloid or lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Major finding: For pediatric patients with very-high-risk acute myeloid leukemia, the 5-year probability of leukemia-free survival was 21%.
Study details: A risk modeling study involving 1,135 children with acute myeloid leukemia and 1,228 with acute lymphoblastic leukemia.
Disclosures: The study was funded by the National Institutes of Health. The investigators disclosed no conflicts of interest.
Qayed M et al. ASCO 2020, Abstract 7503.